Complement abnormality
Information
- Disease name
- Complement abnormality
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04103489 | Completed | Phase 1 | The Use of Eculizumab in HELLP Syndrome | February 23, 2021 | September 4, 2023 |
| NCT04183101 | Recruiting | Phase 2 | Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy | October 1, 2020 | December 2029 |
| NCT05258643 | Recruiting | N/A | The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study | September 1, 2020 | September 1, 2024 |
| NCT04725812 | Terminated | Phase 2 | Complement Regulation to Undo Systemic Harm in Preeclampsia | September 13, 2021 | December 7, 2021 |